Clinical Trial Detail

NCT ID NCT02581059
Title Efficacy of Ginseng for Patients on Regorafenib
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Hoosier Cancer Research Network
Indications

colon adenocarcinoma

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.